RxSight Inc. (RXST)
NASDAQ · Healthcare
RxSight Inc. Shareholder Equity 2020–2025
RxSight Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- RxSight Inc. shareholder equity for the quarter ending December 31, 2025 were 275.7M, a 1.98% decrease year-over-year.
- RxSight Inc. shareholder equity for 2025 were 275.7M, a 1.98% decrease from 2024.
- RxSight Inc. shareholder equity for 2024 were 281.2M, a 75.38% increase from 2023.
- RxSight Inc. shareholder equity for 2023 were 160.4M, a 78.37% increase from 2022.
- RxSight Inc. shareholder equity for 2022 were 89.9M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| RxSight Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $276 |
| 2024 | $281 |
| 2023 | $160 |
| 2022 | $90 |
| 2021 | $138 |
| 2020 | $-431 |
| RxSight Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $276 |
| 2024-12-31 | $281 |
| 2023-12-31 | $160 |
| 2022-12-31 | $90 |
| 2021-12-31 | $138 |
| 2020-12-31 | $-431 |
RxSight Inc. Shareholder Equity — FAQ
RxSight Inc. (RXST) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RXST's shareholder equity history?
The chart and table above show RxSight Inc.'s shareholder equity by year and by quarter, including the growth rate.